Compound information
- Natural Products
- NACP116154
- Molecular Formula
- C12H10O4
- Molecular Weight
- 218.0579088 g/mol
- Structure
-
- IUPAC Name
- 5-(1,3-benzodioxol-5-yl)penta-2,4-dienoic acid
- InChI
- InChI=1S/C12H10O4/c13-12(14)4-2-1-3-9-5-6-10-11(7-9)16-8-15-10/h1-7H,8H2,(H,13,14)
- InChI Key
- RHBGITBPARBDPH-UHFFFAOYSA-N
- SMILES
- O=C(O)C=CC=CC1=CC=C2OCOC2=C1
- CAS
- SuperClass
- Organoheterocyclic compounds
- Class
- Benzodioxoles
- SubClass
- NaN
- Source
- CNP0229122
Warheads
- Acrylate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 16 | Ring Count | 2 |
Heteroatom Count | 4 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 55.76 Å2 | LogP | 2.991 |
LogS | -3.521 | LogD | 1.836 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.972 | Pgp substrate | 0.001 |
HIA | 0.96 | F20 % | 0.984 |
F30 % | 0.748 | Caco-2 | -4.563 |
MDCK | -4.489 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.944 | PPB | 73.082 |
VD | 0.296 | Fu | 0.674 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.968 | CYP1A2 substrate | 0.758 |
CYP2A6 substrate | 0.759 | CYP2B6 substrate | 0.627 |
CYP2C19 inhibitor | 0.027 | CYP2C19 substrate | 0.63 |
CYP2C8 substrate | 0.754 | CYP2C9 inhibitor | 0.07 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.123 |
CYP2D6 substrate | 0.811 | CYP2E1 substrate | 0.715 |
CYP3A4 inhibitor | 0.01 | CYP3A4 substrate | 0.857 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.854 | CL | 13.767 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.02 | Hepatotoxicity | 0.232 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.277 |
FDAMDD | 0.562 | Skin Sensitization | 0.997 |
Carcinogenicity | 0.837 | Eye Corrosion | 0.002 |
Eye Irritation | 0.946 | Respiratory Toxicity | 0.865 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.503 | IGC50 | 3.875 |
LC50FM | 4.527 | LC50DM | 4.732 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.357 | NR-AR-LBD | 0.594 |
NR-AhR | 0.609 | NR-Aromatase | 0.041 |
NR-ER | 0.356 | NR-ER-LBD | 0.402 |
NR-PPAR-gamma | 0.876 | SR-ARE | 0.946 |
SR-ATAD5 | 0.674 | SR-HSE | 0.845 |
SR-MMP | 0.022 | SR-p53 | 0.403 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.